There’s celebrating in the halls — and virtual halls — of Telesis Bio. We are truly honored that our new BioXp® 3250 system was selected as one of the year’s best innovations by The Scientist. This is a very prestigious list and includes technologies across the full spectrum.
“As challenging as 2020 has been for all of us, this tumultuous year has given birth to promising products and approaches for elucidating the complex world of biology,” The Scientist editors wrote in their introduction to this year’s list of winners.
The BioXp® system was summed up by competition judge Paul Blainey, an associate professor of biological engineering at MIT: “Democratizing gene synthesis by placing capability in individual labs for faster turnaround and lower costs at high throughput.” We couldn’t have said it better ourselves.
The Scientist’s staff also reached out to Mark Tornetta, VP of Biologics Discovery at Tavotek Biotherapeutics, for comment on the system. “The BioXp® system has enabled us to perform simple subcloning steps hands-free,” he responded. “All of these methods [that are run] on the BioXp® system save us time and cost to perform.”
We’d like to congratulate our fellow innovators and thank everyone who contributed to the development of the BioXp® system — both our internal team and our customers who provided valuable feedback that helped us improve the platform. We’re raising a toast to all of you.